SCHEMBL6592912

SCHEMBL6592912

CC(C)(C(=O)O)c1ccc([N+](=O)[O-])c(OCc2ccccc2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MYC P01106 1/20 0.48
MAX P61244 1/20 0.48
CTSV O60911 4/20 0.47
CTSL P07711 4/20 0.47
CYP19A1 P11511 1/20 0.46
ABCB1 P08183 1/20 0.46
ALDH1A1 P00352 1/20 0.46
HTT P42858 1/20 0.46
CHEK1 O14757 1/20 0.45
MEN1 O00255 2/20 0.44
MAPT P10636 2/20 0.44
KMT2A Q03164 2/20 0.44
CYP11B1 P15538 1/20 0.44
CYP11B2 P19099 1/20 0.44
POLB P06746 2/20 0.44
SENP8 Q96LD8 1/20 0.44
SENP7 Q9BQF6 1/20 0.44
SENP6 Q9GZR1 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6592921 1.00 MYC (0.48) MYCMAXCTSVCTSLCYP19A1
SCHEMBL23582396 0.90 MYC (0.48) MYCMAXCTSVCTSLCYP19A1
SCHEMBL6593577 0.86 MYC (0.52) MYCMAXCTSVCTSLCYP19A1
SCHEMBL6597864 0.85 NPSR1 (0.48) MYCMAXCTSVCTSLCYP19A1
SCHEMBL6592223 0.85 NPSR1 (0.50) MYCMAXCTSVCTSLCYP19A1
SCHEMBL3922556 0.82 RXRA (0.52) MYCMAXCTSVCTSLALDH1A1
SCHEMBL6688277 0.80 CTSV (0.54) CTSVCTSLCYP19A1ABCB1ALDH1A1
SCHEMBL30184780 0.79 CTSV (0.51) MYCMAXCTSVCTSLCYP19A1
SCHEMBL1040246 0.79 CTSV (0.51) MYCMAXCTSVCTSLCYP19A1
SCHEMBL528177 0.78 MYC (0.67) MYCMAXCTSVCTSLABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1144393-B1 BENZOXAZOLE DERIVATIVES FOR USE AS INTEGRIN INHIBITORS ASTRAZENECA AB (SE) 2004-02-11 EP disclosed
EP-1144393-A3 HETEROCYCLIC DERIVATIVES AND THEIR USE AS INTEGRIN INHIBITOR AstraZeneca AB (SE) 2002-09-11 EP disclosed
US-6441012-B1 BENZOXAZOLE OR BENZTHIAZOLE DERIVATIVES FOR INHIBITING THE INTERACTION BETWEEN CELLULAR ADHESION MOLECULES AND/OR FIBRONECTIN AND THE INTERGRIN RECEPTOR ASTRAZENECA AB (SE) 2002-08-27 US disclosed
EP-1144393-A2 HETEROCYCLIC DERIVATIVES AND THEIR USE AS INTEGRIN INHIBITOR AstraZeneca AB (SE) 2001-10-17 EP disclosed
EP-1133484-A2 HETEROCYCLIC DERIVATIVES AND THEIR USE AS INTEGRIN INHIBITORS AstraZeneca AB (SE) 2001-09-19 EP disclosed
WO-2000005223-A2 HETEROCYCLIC DERIVATIVES AND THEIR USE AS INTEGRIN INHIBITORS ASTRAZENECA AB (SE) 2000-02-03 WO disclosed
WO-2000005224-A2 HETEROCYCLIC DERIVATIVES AND THEIR USE AS INTEGRIN INHIBITOR ASTRAZENECA AB (SE) 2000-02-03 WO disclosed